Azole resistance in Candida albicans.

Collaborative comparison of broth macrodilution and microdilution antifungal susceptibility tests. J Clin Microbiol (1992) 12.13

Antifungal susceptibility testing. Clin Microbiol Rev (1993) 9.04

Resistance of Candida species to fluconazole. Antimicrob Agents Chemother (1995) 9.04

Multicenter evaluation of a broth macrodilution antifungal susceptibility test for yeasts. Antimicrob Agents Chemother (1993) 8.36

Antifungal agents: mode of action, mechanisms of resistance, and correlation of these mechanisms with bacterial resistance. Clin Microbiol Rev (1999) 5.51

Fluconazole resistance in Candida glabrata. Antimicrob Agents Chemother (1993) 4.04

Emergence of fluconazole-resistant strains of Candida albicans in patients with recurrent oropharyngeal candidosis and human immunodeficiency virus infection. J Clin Microbiol (1994) 3.51

Genetics of Candida albicans. Microbiol Rev (1990) 3.51

Characterization of an azole-resistant Candida glabrata isolate. Antimicrob Agents Chemother (1992) 3.23

Molecular biological characterization of an azole-resistant Candida glabrata isolate. Antimicrob Agents Chemother (1997) 2.27

Susceptibility testing of fungi: current status of correlation of in vitro data with clinical outcome. J Clin Microbiol (1996) 2.19

Variation in fluconazole efficacy for Candida albicans strains sequentially isolated from oral cavities of patients with AIDS in an experimental murine candidiasis model. Antimicrob Agents Chemother (1996) 1.28

In vitro activity of D0870 compared with those of other azoles against fluconazole-resistant Candida spp. Antimicrob Agents Chemother (1995) 0.99

Recurrent vaginal candidosis: prospective study of effectiveness of maintenance miconazole treatment. Genitourin Med (1988) 0.83

Antidermatophytic Activity of the Fruticose Lichen Usnea orientalis. Medicines (Basel) (2016) 0.75

Identification of FAP locus genes from chromosome 5q21. Science (1991) 11.41

Enhanced differentiation of isolates of Candida albicans using a modified resistogram method. Mykosen (1982) 7.04

Identification of a gene located at chromosome 5q21 that is mutated in colorectal cancers. Science (1991) 6.15

Itraconazole resistance in Aspergillus fumigatus. Antimicrob Agents Chemother (1997) 4.75

Antifungal susceptibility testing: practical aspects and current challenges. Clin Microbiol Rev (2001) 4.49

Inhibitors of protein synthesis and RNA synthesis prevent neuronal death caused by nerve growth factor deprivation. J Cell Biol (1988) 4.06

Fluconazole resistance in Candida glabrata. Lancet (1988) 4.05

Fluconazole resistance in Candida glabrata. Antimicrob Agents Chemother (1993) 4.04

BAX is required for neuronal death after trophic factor deprivation and during development. Neuron (1996) 4.02

Trends in mortality due to invasive mycotic diseases in the United States, 1980-1997. Clin Infect Dis (2001) 3.68

Correlation between in-vitro susceptibility testing to itraconazole and in-vivo outcome of Aspergillus fumigatus infection. J Antimicrob Chemother (1997) 3.40

Disruption of the Jak1 gene demonstrates obligatory and nonredundant roles of the Jaks in cytokine-induced biologic responses. Cell (1998) 3.25

Standardized susceptibility testing of fluconazole: an international collaborative study. Antimicrob Agents Chemother (1992) 3.19

Nature of lactose-fermenting Salmonella strains obtained from clinical sources. J Bacteriol (1969) 3.14

Induction of BIM, a proapoptotic BH3-only BCL-2 family member, is critical for neuronal apoptosis. Neuron (2001) 3.07

Detection of FeLV antigen by indirect immunofluorescence in ELISA/CITE negative cats. Vet Rec (1995) 3.05

Resistogram method for differentiation of strains of Candida albicans. J Appl Bacteriol (1979) 2.97

Intergeneric bacterial matings. Bacteriol Rev (1968) 2.94

Correlation of MIC with outcome for Candida species tested against voriconazole: analysis and proposal for interpretive breakpoints. J Clin Microbiol (2006) 2.86

Emergence of azole drug resistance in Candida species from HIV-infected patients receiving prolonged fluconazole therapy for oral candidosis. J Antimicrob Chemother (1995) 2.83

Vaginal candidiasis and the role of the digestive tract as a source of infection. Br J Obstet Gynaecol (1975) 2.76

In vitro studies of activity of voriconazole (UK-109,496), a new triazole antifungal agent, against emerging and less-common mold pathogens. Antimicrob Agents Chemother (1997) 2.75

Altered gene expression in neurons during programmed cell death: identification of c-jun as necessary for neuronal apoptosis. J Cell Biol (1994) 2.75

Temporal analysis of events associated with programmed cell death (apoptosis) of sympathetic neurons deprived of nerve growth factor. J Cell Biol (1993) 2.67

Comparison of high-fat and high-protein diets with a high-carbohydrate diet in insulin-resistant obese women. Diabetologia (2004) 2.66

Caspase inhibitor affords neuroprotection with delayed administration in a rat model of neonatal hypoxic-ischemic brain injury. J Clin Invest (1998) 2.64

Molecular determinants of dysplasia in colorectal lesions. Cancer Res (1994) 2.62

Aspergillus antigen latex test for diagnosis of invasive aspergillosis. Lancet (1991) 2.59

Analysis of cell cycle-related gene expression in postmitotic neurons: selective induction of Cyclin D1 during programmed cell death. Neuron (1994) 2.54

Evidence of a novel event during neuronal death: development of competence-to-die in response to cytoplasmic cytochrome c. Neuron (1998) 2.49

Mucormycosis during deferoxamine therapy is a siderophore-mediated infection. In vitro and in vivo animal studies. J Clin Invest (1993) 2.45

In-vitro resistance to imidazole antifungals in Candida albicans. J Antimicrob Chemother (1984) 2.43

Candida dubliniensis fungemia: the first four cases in North America. Emerg Infect Dis (2000) 2.34

Regional brain blood flow in man during acute changes in arterial blood gases. J Physiol (2012) 2.34

Mechanisms and clinical impact of antifungal drug resistance. J Med Vet Mycol (1994) 2.32

Two human T cell receptors bind in a similar diagonal mode to the HLA-A2/Tax peptide complex using different TCR amino acids. Immunity (1998) 2.31

Illiteracy among Medicaid recipients and its relationship to health care costs. J Health Care Poor Underserved (1994) 2.30

GFR alpha1-deficient mice have deficits in the enteric nervous system and kidneys. Neuron (1998) 2.29

Incidence of invasive aspergillosis following hematopoietic stem cell and solid organ transplantation: interim results of a prospective multicenter surveillance program. Med Mycol (2005) 2.29

Management and outcome of bloodstream infections due to Candida species in England and Wales. J Hosp Infect (2003) 2.29

The preparation and antimycotic properties of derivatives of 1-phenethylimidazole. J Med Chem (1969) 2.28

Molecular biological characterization of an azole-resistant Candida glabrata isolate. Antimicrob Agents Chemother (1997) 2.27

The clinical pharmacokinetics of itraconazole: an overview. Mycoses (1989) 2.27

Granulocyte colony-stimulating factor as a marker for bacterial infection in neonates. J Pediatr (1996) 2.27

Ketoconazole -- a new broad spectrum orally active antimycotic. Experientia (1979) 2.24

Gene targeting reveals a critical role for neurturin in the development and maintenance of enteric, sensory, and parasympathetic neurons. Neuron (1999) 2.22

Quantitation of Candida albicans ergosterol content improves the correlation between in vitro antifungal susceptibility test results and in vivo outcome after fluconazole treatment in a murine model of invasive candidiasis. Antimicrob Agents Chemother (2000) 2.22

Genetic analysis of the ViA-his chromosomal region in Salmonella. J Bacteriol (1966) 2.17

Multilocus linkage identifies two new loci for a mendelian form of stroke, cerebral cavernous malformation, at 7p15-13 and 3q25.2-27. Hum Mol Genet (1998) 2.16

Characterization of transmissible genetic elements from sucrose-fermenting Salmonella strains. J Bacteriol (1975) 2.11

Desmoplastic malignant melanoma. J Am Acad Dermatol (1995) 2.08

Association between wild type and mutant APC gene products. Cancer Res (1993) 2.08

An initiation zone of chromosomal DNA replication located upstream of the c-myc gene in proliferating HeLa cells. Mol Cell Biol (1990) 2.08

Pathogenesis of Guillain-Barré syndrome. J Neuroimmunol (1999) 2.08

The characterization of novel, dual ErbB-2/EGFR, tyrosine kinase inhibitors: potential therapy for cancer. Cancer Res (2001) 2.06

Induction of nerve growth factor receptor in Schwann cells after axotomy. Proc Natl Acad Sci U S A (1986) 2.06

Mechanism of tolerance development to organic nitrates. J Pharmacol Exp Ther (1973) 2.04

Nerve growth factor deprivation results in the reactivation of latent herpes simplex virus in vitro. J Virol (1987) 2.01

BH3-only Bcl-2 family members are coordinately regulated by the JNK pathway and require Bax to induce apoptosis in neurons. J Biol Chem (2001) 2.01

Treatment of vaginal candidiasis with ketoconazole, a new, orally active, antimycotic. Eur J Obstet Gynecol Reprod Biol (1979) 2.01

The HeLa Pur factor binds single-stranded DNA at a specific element conserved in gene flanking regions and origins of DNA replication. Mol Cell Biol (1992) 2.00

Genomic profiling of the response of Candida albicans to itraconazole treatment using a DNA microarray. Antimicrob Agents Chemother (2001) 1.99

Wild-type MIC distribution and epidemiological cutoff values for Aspergillus fumigatus and three triazoles as determined by the Clinical and Laboratory Standards Institute broth microdilution methods. J Clin Microbiol (2009) 1.99

In-vitro activity of voriconazole, itraconazole and amphotericin B against filamentous fungi. J Antimicrob Chemother (1998) 1.98

Superoxide dismutase delays neuronal apoptosis: a role for reactive oxygen species in programmed neuronal death. Neuron (1995) 1.95

Typing of Candida albicans. J Hosp Infect (1984) 1.93

Bax deletion further orders the cell death pathway in cerebellar granule cells and suggests a caspase-independent pathway to cell death. J Cell Biol (1997) 1.89

Artemin, a novel member of the GDNF ligand family, supports peripheral and central neurons and signals through the GFRalpha3-RET receptor complex. Neuron (1998) 1.89

Clinical pharmacokinetics of systemic antifungal drugs. Clin Pharmacokinet (1983) 1.88

The GDNF family ligands and receptors - implications for neural development. Curr Opin Neurobiol (2000) 1.88

RET signaling is essential for migration, axonal growth and axon guidance of developing sympathetic neurons. Development (2001) 1.86

Comparison of E-test and broth microdilution methods for antifungal drug susceptibility testing of molds. J Clin Microbiol (1999) 1.85

Pharmacokinetics of ketoconazole in normal subjects. J Antimicrob Chemother (1981) 1.84

Neurturin, a relative of glial-cell-line-derived neurotrophic factor. Nature (1996) 1.83

Itraconazole, a new triazole that is orally active in aspergillosis. Antimicrob Agents Chemother (1984) 1.83

Multicenter evaluation of Microring YT, a new method of yeast identification. J Clin Microbiol (1990) 1.83

Reversible changes in nucleosome structure and histone H3 accessibility in transcriptionally active and inactive states of rDNA chromatin. Cell (1983) 1.82

Biochemical targets for antifungal azole derivatives: hypothesis on the mode of action. Curr Top Med Mycol (1985) 1.82

Antigenic variability of Candida albicans. Crit Rev Microbiol (1985) 1.79

Antimycotic imidazoles. part 4. Synthesis and antifungal activity of ketoconazole, a new potent orally active broad-spectrum antifungal agent. J Med Chem (1979) 1.78

Expression of the APC tumor suppressor protein in oligodendroglia. Glia (1996) 1.77

Inactivation of both APC alleles in human and mouse tumors. Cancer Res (1994) 1.75

Epidemiology, clinical manifestations, and therapy of infections caused by dematiaceous fungi. J Chemother (2003) 1.75

Assay of typhoid vaccines with Salmonella typhosa-Salmonella typhimurium hybrids. Infect Immun (1973) 1.72

Computer-assisted rapid enzyme-linked immunosorbent assay (ELISA) in the serological diagnosis of aspergillosis. J Immunol Methods (1983) 1.70

Epidemiological investigation of patients with vulvovaginal candidosis. Application of a resistogram method for strain differentiation of Candida albicans. Br J Vener Dis (1979) 1.70

Trends in antifungal drug susceptibility of Cryptococcus neoformans isolates in the United States: 1992 to 1994 and 1996 to 1998. Antimicrob Agents Chemother (2001) 1.70

Nerve growth factor-dependence of herpes simplex virus latency in peripheral sympathetic and sensory neurons in vitro. J Neurosci (1990) 1.69

Mechanisms of thrombin generation during surgery and cardiopulmonary bypass. Blood (1993) 1.69

A reevaluation of risk of in utero exposure to lithium. JAMA (1994) 1.68